InvestSMART

Wall Street mixed in late trade

Markets lifted by M&A activity after struggling for direction in morning trade.
By · 19 Feb 2014
By ·
19 Feb 2014
comments Comments
Upsell Banner

United States stocks have kicked off a holiday-shortened week mixed as investors weigh Irish drug maker Actavis's mega deal to acquire Forest Laboratories and disappointing earnings from Coca-Cola.

At the closing bell, the Dow Jones Industrial Average was down 23.99 points, or 0.15%, at 16,130.40.

The broad S&P 500 index added 2.13 points, or 0.12%, to 1,840.76, while the tech-heavy Nasdaq Composite rose 28.76 points, or 0.68%, to 4,272.78.

"This morning's $US25 billion ($A27.77 billion) M&A deal of Irish drug-maker Actavis acquiring Forest Labs raises M&A market interest even further," said Fred Dickson of DA Davidson & Co.

"We expect a steady stream of new M&A announcements in coming months, as corporations feel pressured to commit cash sitting on the sidelines to drive future earnings."

Generic drug maker Actavis will pay $89.48 per Forest share to buy the specialty pharmaceutical firm, a premium of about 25% over Forest's share price, the companies announced.

US-traded shares in Dublin-based Actavis shares surged 6.4% to $204.05 and Forest Labs soared 28.8% to $91.96.

Dow member Coca-Cola dropped almost 4% after reporting fourth-quarter revenue that missed Wall Street expectations.

IPhone maker Apple rose 0.8%, helped by press reports it is in talks to buy electric car maker Tesla Motors. Tesla advanced 3.5%.

News the developer behind the popular Candy Crush puzzle game, King Digital Entertainment, is seeking a listing on the New York Stock Exchange rippled through tech stocks.

Candy Crush is available on Facebook (-0.8%) and on mobile platforms run by Apple, Google ( 0.2%) and Amazon (-1.3%).

Bond prices rose. The yield on the 10-year US Treasury dropped to 2.69% from 2.75% on Friday, while the 30-year fell to 3.68% from 3.70%. Bond prices and yields move inversely.

Share this article and show your support
Free Membership
Free Membership
AFP
AFP
Keep on reading more articles from AFP. See more articles
Join the conversation
Join the conversation...
There are comments posted so far. Join the conversation, please login or Sign up.